HIF1A and AIDS: Collectively, these findings suggest that inhibiting metabolic reprogramming of macrophages and downregulating HIF-1α expression in the hypoxic microenvironment may represent viable therapeutic strategies for alleviating tissue inflammation in patients with AIDs.